Results 1 to 10 of about 2,020,141 (269)

Regulation of cAMP levels in osteocytes by mechano-sensitive focal adhesion kinase and phosphodiesterase 8A. [PDF]

iScience
Papaioannou G, Sato T, Houghton C, Yan C, Kotsalidis PE, Strauss KE, Dean T, Mazur CM, Nelson AJ, Stokes MP, Gardella TJ, Wein MN.   +11 more
europepmc   +1 more source

High-throughput identification of bacterial β-glucuronidase inhibitors using machine learning. [PDF]

Gut Microbes
Zhang B, Yue H, Skalse A, Sangfuang N, Shorthouse D, Gaisford S, Basit AW.   +6 more
europepmc   +1 more source

Expert Consensus on the Clinical Application of Poly ADP Ribose Polymerase Inhibitors in Breast Cancer (2025 Edition). [PDF]

Cancer Innov
Ma F, Xu B, China Anti‐Cancer Association Committee on Clinical Research of Anticancer Drugs, National Expert Committee on Monitoring Clinical Application of Antineoplastic Drugs, Breast Cancer Expert Committee of National Cancer Quality Control Center, Expert Committee on Chemotherapy Quality Control of Beijing Cancer Treatment Quality Control and Improvement Center.   +5 more
europepmc   +1 more source

Viral dsRNA triggers human fetal membrane miR-146a-3p to be packaged into small extracellular vesicles which in turn drives inflammation through activation of Toll-like Receptor 7 and 8. [PDF]

PLoS One
Georges HM, Fischer AC, Casanova P, Abrahams VM.   +3 more
europepmc   +1 more source

Progressive loss of glycemic control during chronic DPP-4 inhibitor therapy despite preserved β-cell function: a case report suggesting acquired incretin resistance. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Prasad S, Ahuja A, Sharma S, Nagda J, Agrawal S, Parmar V, Vardhan H.   +6 more
europepmc   +1 more source

Pharmacist Outreach and SGLT2 Inhibitor Uptake in Patients With Diabetes and Chronic Kidney Disease.

JAMA Netw Open
Pestka DL, Murphy D, Kaplan AN, Taylor BC, Huynh P, Rechtzigel JA, Kjos S, Ellich LM, Atwood M, Polsfuss BA, Thomas AR, Lee JY, Ishani A.   +12 more
europepmc   +1 more source

Long-Term Efficacy and Safety of GLP-1R Agonist and SGLT2 Inhibitor Therapy in the General Population: A Mendelian Randomization Study. [PDF]

Circ Genom Precis Med
Remala S, Liang L, Shah AM, Buckley LF.
europepmc   +1 more source